Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
From Iskomunidad
mNo edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
'''Resource Person'''<br /> | '''Resource Person'''<br /> | ||
[http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar Lie] | [http://www.bioethics.nih.gov/people/cv/Lie_CV_Nov11.pdf Dr Reidar Lie]<br /> | ||
Adjunct Research Fellow<br /> | |||
Department of Bioethics<br /> | |||
Clinical Center<br /> | |||
National Institutes of Health, USA | |||
<br /><br /> | <br /><br /> | ||
==See Also== | ==See Also== | ||
[[“Ethical, Legal, Social Issues” (ELSI) Program]], [http://pgc.up.edu.ph Philippine Genome Center] | [[“Ethical, Legal, Social Issues” (ELSI) Program]], [http://pgc.up.edu.ph Philippine Genome Center] | ||
Revision as of 21:07, 26 October 2012
"Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012
University of the Philippines - Manila
Resource Person
Dr Reidar Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center